Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Minimally Invasive Esophagectomy Improves Survival

By HospiMedica staff writers
Posted on 13 May 2003
The results of the largest study to date evaluating minimally invasive esophagectomy (MIE) to treat esophageal cancer show that the procedure reduces mortality rates and hospital stays compared to most open procedures. More...
These results were reported at the annual meeting of the American Surgical Association in Washington, DC (USA).

Researchers evaluated MIE in 221 patients, comparing hospital stays and mortality rates with similarly sized studies of open methods, including thoracotomy and laparotomy, or both. The results showed that the median hospital stay was seven days for patients with MIE, compared to more than 10 days for patients with open procedures. Also, mortality occurred in 1.3% of the MIE patients, compared to rates of up to 5% or higher reported for open procedures.

MIE is a video-assisted surgical procedure that utilizes instruments introduced into the body through very small incisions and a laparoscope. Patients who are candidates for MIE undergo extensive preoperative evaluation involving laparoscopic staging, endoscopic ultrasound, and computed tomography (CT) scans to assess the extent of the disease.
"Our study demonstrates that minimally invasive esophagectomy offers results as good as, if not better than, open esophageal procedures,” said Dr. James D. Luketich, associate professor of surgery, University of Pittsburgh Medical Center (PA, USA). However, Dr. Luketich stressed that the success of esophagectomy, regardless of method used, largely depends on surgical expertise in the procedure and a high volume of procedures performed annually.





Related Links:
U. of Pittsburgh

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.